Replies to post #10840 on Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

In terms of the milestones for new indications, the license agreement hasn't really changed. $35 million in total milestones that are somehow divided up between the following (Titan redacted confidential portions iwth actual amounts to be paid):

"(ii) Submission of NDA for Subsequent Indication of chronic pain
***
(iii) FDA Approval of NDA for Subsequent Indication of chronic pain
***
(iv) Submission of NDA for each additional Subsequent Indication (i.e., not for chronic pain)
***
(v) FDA Approval of NDA for each additional Subsequent Indication (i.e., not for chronic pain)"

https://www.sec.gov/Archives/edgar/data/910267/000119312513084113/d493585dex101.htm